Unified Flu, COVID and RSV Vaccine Guidance: What the Medical Groups Agreed On
Summary: This article explains why four major physician organizations issued a joint set of respiratory virus vaccine recommendations, how the guidance was developed, and what it means for different patients.
Respiratory virus season creates a practical problem for doctors: flu, COVID-19 and RSV can arrive around the same time, and not every patient needs the same shots. This season, four physician organizations tried to make that decision easier. The American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America issued a shared set of vaccine recommendations for the upcoming respiratory virus season.
The guidance spans the full age range. It covers infants and children, working-age adults, and older adults. It also makes specific provision for people who are pregnant and people with compromised immune systems. In short, this is not simply a reminder to get a flu shot. It is a coordinated statement about which respiratory viruses to vaccinate against, how to weigh timing, and how to approach patients with different levels of risk.
Four groups, one set of recommendations
The four organizations come from different specialties. Family physicians, pediatricians, obstetrician-gynecologists, and infectious disease specialists each see their own slice of the patient population. When they agree on a single set of recommendations, it signals that the advice has been reviewed from multiple clinical angles rather than from the viewpoint of one field.
How the guidance was built
The recommendations were not pulled together quickly. They came out of a structured, evidence-based review process designed to assess vaccine safety and effectiveness for the 2026–2027 respiratory virus season. The results were posted at SpreadTheFacts.org, a new website set up by the American Medical Association to make the guidance available to the public.
That review process matters because respiratory virus vaccines are updated and re-evaluated regularly. Protection can vary from season to season, and new data can change the balance of who should be vaccinated first or whether a particular group should get an additional dose.
What the guidance covers, and what it does not
The public summary of the guidance describes the scope: patients from birth through older adulthood, plus pregnant people and those with weakened immune systems. It does not, in the available public detail, list specific vaccine brand names, exact dose counts, or every age cutoff. For those specifics, the groups point to SpreadTheFacts.org and to individual clinicians.
That means the practical takeaway is not a one-size-fits-all schedule. A pregnant patient will likely hear something different from an older adult, and a younger, healthy patient may not need the same protection at the same time as someone with an underlying condition. The unified guidance gives doctors a shared starting point; the final call still depends on the patient.
Why the agreement matters
For most people, the value of a joint recommendation is consistency. During a season when flu, COVID and RSV overlap, it is easier for a doctor to discuss all three vaccines in one conversation when professional groups are on the same page. It also helps patients who see different providers, or who hear different advice from friends and relatives, understand that the medical profession is not split on the basics.
None of this guarantees that every eligible person will get vaccinated. But it provides a clear reference point for doctors and patients alike. The agreement among these four organizations is an attempt to take some of the guesswork out of the respiratory virus season.